GLP1R expression in prostate cancer patients and effects of GLP1R agonism on prostate cancer cells.
Sign Up to like & getrecommendations! Published in 2025 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2025.43.5_suppl.182
Abstract: 182 Background: As a disease of aging, metabolic co-morbidities are managed concurrently with prostate cancer. Recent FDA approvals have launched widespread use of GLP1 receptor agonist semaglutide for Type II Diabetes Mellitus and obesity. Mechanistically,… read more here.
Keywords: cancer; glp1r expression; prostate cancer; agonism ... See more keywords